Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice.
Neuroscience
; 259: 126-41, 2014 Feb 14.
Article
em En
| MEDLINE
| ID: mdl-24316474
Palavras-chave
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; ANOVA; CREB; Ca(2+)/calmodulin-dependent protein kinase II; CaMKII; DAB; DARPP-32; ECD; ERK; HPLC; LTP; MPTP; PBS; PD; PDE; PET; PKA; PKC; Parkinson's disease; SN; SNpc; TH; VDCCs; VTA; Voltage-dependent Ca(2+) channel; analysis of variance; cAMP-dependent protein kinase; cognitive function; cyclic-AMP-responsive-element-binding protein; diaminobenzidine; dopamine- and cAMP-regulated phosphoprotein-32; electrochemical detector; extracellular signal-regulated kinase; high-performance liquid chromatography; long-term potentiation; nobiletin; phosphate-buffered saline; phosphodiesterase; positron emission tomography; protein kinase C; substantia nigra; substantia nigra pars compacta; tyrosine hydroxylase; ventral tegmental area; voltage-dependent Ca(2+) channels
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Transtornos Cognitivos
/
Transtornos Parkinsonianos
/
Flavonas
/
Atividade Motora
/
Antioxidantes
Limite:
Animals
Idioma:
En
Revista:
Neuroscience
Ano de publicação:
2014
Tipo de documento:
Article